In mouse xenografts derived from 3D co-cultures of H460 cells and HUVECs, the combination of gefitinib and CHIR99021 reduced tumor size, decreased Ki-67-positive proliferating cells and CD31-positive endothelial cells, and lowered the fibrotic burden. Here, PECAM1 is linked to neoplasm.